Back to results
US 2025/0325544 A1Published application
Cdk inhibitors
AssigneeGenentech, Inc.
InventorsZhilong HU, Hu HE, Fei ZHANG, Wenge ZHONG, Xiaotian ZHU
Life of this patent
Estimating the term…
Abstract
The invention provides a compound represented by represented by the following strutural formula: or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.
Claims11
A compound represented by the following structural formula:
- or a pharmaceutically acceptable salt or a stereoisomer thereof.
Dependencies are inferred from the claim text.